In the only reported trial to date involving people with AUD who actively wished to reduce or cease drinking, a once-weekly GLP-1 agonist called exenatide did not result, in the overall group, in a reduction of the number of heavy drinking days, but the drug did enable those with AUD and obesity to do so
10.1155/2022/8548378 14 Garca-MuozA
Phase 3 trials (the final stage before approval) offer free medication and monitoring in exchange for participation
Although the Philippines graduated to the rank of (lower) middleincome country in 2009 (UNDP, n.d.), the country's malnutrition rates remain high: about onethird of children in the Philippines are stunted, and onefifth are underweight (Department of Health 2017)
The manufacturer of Victoza added 3 patents after paragraph IV certification, while the manufacturer of Saxenda added 1 patent (eTable 2)
Those with B-12 deficiencies may experience brain fog, memory problems, or mood disturbances, which can be mitigated with regular injections